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Abstract
Purpose: Changes in weight-bearing patterns after partial foot amputations may lead to new localized high-pressure
points and keratosis due to ulcerations in patients with neuropathies and hypovascular limbs. As a result, diabetic foot
ulcers (DFUs) after partial foot amputations are very complex. The aim of this study was to compare the effectiveness of
vacuum-assisted closure (VAC) therapy with conventional moist wound dressings in the treatment of diabetic wound
ulcers after partial foot amputations. Methods: Sixty-five diabetic patients with a DFU, who had previously undergone
partial foot amputation surgery, were assigned to treatment with VAC (group A: 31 patients) or conventional wound
moist dressing (group B: 34 patients). The final results were considered as failed treatment if reamputation was required.
Conversely, reaching 90% of wound granulation was considered to be a successful endpoint. Results: The average time to
reach 90% granulation tissue was significantly lower in group A (7.8 + 1.2 weeks vs. 11.1 + 1.2 weeks; p < 0.001).
However, there was no significant difference regarding the reamputation requirements; 38.7% (12 patients) in group A and
41.2% (14 patients) in group B, (p ¼ 0.839). Conclusion: The results of this study allowed us to conclude that VAC
therapy system appears to be an effective treatment for patients with complex DFUs who had previously undergone
partial foot amputation.
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Introduction
Half of the 80,000 amputations per year related to diabetes
in the United States are reported to be partial foot amputa-
tions.1 After partial foot amputations, complications that
may cause deformities could lead to further ulcerations.
Changes in weight-bearing patterns may lead to new loca-
lized high-pressure points and keratosis due to ulcerations
in patients with neuropathies and hypovascular limbs.2,3 As
a result, diabetic foot ulcers (DFUs) after partial foot ampu-
tations are very complex. Patients often experience chal-
lenges with healing and are often faced with high rates of
complications.4–6 The wounds are often large and deep
with exposed bone and tendons occurring in patients with
compromised healing capacity and significant risk factors
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for reamputation.7,8 After amputations of the lower limb,
only 40–50% of amputees survive for 5 years and the prog-
nosis worsens as the level of amputation goes higher up the
leg.9 There are different treatment methods for DFUs, such
as moist wound dressings, hydrocolloid wound gels,
growth factors, enzymatic debridement compounds, elec-
tric stimulation, low-potential laser therapy, and negative-
pressure wound therapy (NPWT).8,10 NPWT, with
Vacuum-Assisted Closure® (VAC®) which was introduced
in 1997 by Argenta and Morykwas,10,11 seems to be the
most widely used variant. NPWT improves local blood
supply and stimulates local angiogenesis, thus increasing
the formation of granulation tissue over clean wounds. As a
result, fibroblasts migrate, contracting and reducing the
surface area of the wound.12–14 The aim of this study was
to compare the effectiveness of VAC with conventional
moist wound dressings in the treatment of diabetic wound
ulcers after partial foot amputations.
Material and methods
This study was approved by the institutional review board
of our institution under process number 04/269. All patients
participating in the study provided informed consent orally
before the study. Sixty-five diabetic patients with a DFU,
who had previously undergone partial foot amputation sur-
gery, were assigned to treatment with VAC (group A: 31
patients) or conventional wound moist dressing (group B:
34 patients). VAC dressings were administered after proper
debridement surgery and the dressings were changed once
every 3 days. The moist dressings were changed twice daily
after washing the ulcer with sterile saline and gauze. The
inclusion criteria consisted of the following: the patients in
whom partial foot amputations were performed below the
talocalcaneal joint, with DFU located outside of the ampu-
tation region. The exclusion criteria included the following:
renal failure undergoing dialysis, poor compliance with
medical treatments, receiving radiation therapy or che-
motherapy, osteomyelitis, and ischemic ulcer that needed
any open or endovascular revascularization. The type of
diabetes mellitus, duration of existence of the ulcer, wound
location, and frequency of the underlying disease were
evaluated in all patients. The final results were considered
as failed treatment if reamputation was required. Conver-
sely, reaching 90% of wound granulation was considered to
be a successful endpoint. NPWT delivered through the
VAC System TM (KCI, San Antonio, Texas, USA) was
administered in the present study (13). The system used
in this case consisted of two components, a negative
pressure-generating unit with a disposable canister and a
pad with an evacuation tube. The system unit was pro-
grammed to deliver controlled negative pressures ranging
from 50 mmHg to 200 mmHg. NPWT was applied to the
ulcer as specified by the manufacturer’s guidelines.15
Data analysis
The data were evaluated using SPSS for Windows 15.0
software (SPSS Inc, Chicago, Illinois, USA). The descrip-
tive statistics were calculated as frequencies and percen-
tages for the categorical variables, and as mean, standard
deviation, and median for the numerical variables. As the
numerical variables did not require normal distributions,
the comparison of the two independent groups was per-
formed using the Mann–Whitney U test. The w2 test was
used to compare the rates in the groups. The significance
level was set at 0.05.
Results
There was no statistically significant difference in the
patients’ demographics between the two groups (Table 1).
The regions where the DFUs newly formed were as fol-
lows: sole region 43% (28 patients), metatarsal region
30.7% (20 patients), and phalanx region 26.1%
(17 patients).
The average time to reach 90% granulation tissue was
significantly lower in group A (7.8 + 1.2 weeks vs. 11.1 +
1.2 weeks; p < 0.001) (Figure 1). However, there was no
significant difference regarding the reamputation require-
ments; 38.7% (12 patients) in group A and 41.2% (14
patients) in group B, (p ¼ 0.839) (Table 1). The only pre-
dictive factor which was related to the success of the treat-
ment (90% tissue granulation) in both groups was found to
be the Wagner type 2 ulcer (p ¼ 0.042) (Figure 2).
Discussion
This study suggested that the VAC therapy system yielded
faster times to wound closure in the treatment of diabetic
wound ulcers after partial foot amputation when compared
to the moist dressing. However, there was no difference
regarding the reamputation requirements. VAC is a well-
tolerated technique which generates robust granulation tis-
sue and is becoming a popular treatment modality in the
current practice of wound care compared to other available
therapies.10,11,15,16 Thus, we planned to use VAC therapy in
the treatment of DFU. In their study, McCallon et al.
reported that the mean treatment duration for VAC therapy
and moist dressings was 22.8 and 42.8 days, respectively.
In the VAC group, the mean duration for changes in the
size of the ulcers was 3 weeks less than in the moist dres-
sing group.17 In contrast to the criterion that McCallon
et al. used in their study, we used the formation of adequate
granulation tissue as an endpoint rather than complete
wound regeneration, and we obtained similar results.
Ravari et al. evaluated the effectiveness of VAC therapy
on the size and the depth of the ulcer, and they found a
significant improvement in the wound owing to reduced
diameter and depth.7 The strength of our study is that our
study population particularly included patients with DFU
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who had undergone partial foot amputation. Partial foot
amputation changes the weight-bearing biomechanics of
the foot, making patients susceptible to new pressure points
that can ulcerate. Adequate blood supply, which is gener-
ally present in neuropathic feet, is of paramount importance
for success in wound healing with these procedures. How-
ever, there is still a risk of re-ulceration and further ampu-
tation after partial foot amputations even if the wound has
healed.2 Previous studies primarily focused on DFU in
which previous amputation surgery had not been per-
formed. All of these studies reported better and faster
wound healing in patients after VAC therapy.10,15,18 On the
other hand, there are only few studies in the literature that
focused on the effectiveness of the VAC therapy system in
the treatment of patients with DFU who had previously
undergone a partial foot amputation surgery. Armstrong
and Frykberg reported that, VAC therapy led to a higher
proportion of healed wounds, faster healing rates, and less
reamputation requirement. They attributed the decreases in
reamputations to the faster healing times and higher
proportion of healing wounds with the use of VAC
therapy.4We found a similar superiority in VAC therapy
Figure 1. VAC therapy system yielded shorter times to wound
closure when compared to moist dressings. VAC: vacuum-
assisted closure.
Figure 2. Photograph of a 51-year-old man who had previously
undergone tarsometatarsal amputation. (a) The diabetic wound
ulcer before the application of VAC therapy. (b) The ulcer size
was 8  5 cm and classified as Wagner type 3. (c) After 13 VAC
applications over 8 weeks, the ulcer size decreased by nearly 50%,
and 90% tissue granulation was obtained. VAC: vacuum-assisted
closure.
Table 1. Patient demographics and results.
Group A Group B p
Age, mean + SD (min–max) 60.6 + 11.6 (38–81) 58.3 + 8.0 (47–75) 0.349
Sex Women 6 (19.4) 7 (20.6) 0.901
Men 25 (80.6) 27 (79.4)
Type of DM Type 1 2 (6.5) 3 (8.8) 1.000
Type 2 29 (93.5) 31 (91.2)
Current tobacco use, n (%) 11 (35.5) 11 (32.4) 0.790
Current alcohol use, n (%) 7 (22.6) 6 (17.6) 0.619
Ulcer duration (month), mean + SD (min–max) 3.6 + 2.1 (1–8) 2.9 + 1.6 (1–7) 0.215
Wagner’s scale Grade 2 4 (12.9) 6 (17.6) 0.736
Grade 3 27 (87.1) 28 (82.4)
Size of ulcer (cm2), mean + SD (min–max) 18.3 + 3.1 (12–24) 17.6 + 3.3 (10–24) 0.372
Depth of ulcer (mm), mean + SD (min–max) 11.5 + 1.6 (9–14) 11.4 + 1.8 (8–15) 0.841
Initial amputation level, n (%) Phalanx 9 (29.0) 8 (23.5) 0.614
Trans-metatarsal 7 (22.6) 10 (29.4) 0.531
Tarsometatarsal 10 (32.3) 11 (32.4) 0.993
Chopard 5 (16.1) 6 (17.6) 0.870
Endpoint reached, n (max–min) 90% tissue granulation 19 (61.3) 20 (58.8)
Reamputation requirement 12 (38.7) 14 (41.2) 0.839
Time of 90% tissue granulation (week), mean + SD 7.8 + 1.2 11.1 + 1.2 <0.001
SD: standard deviation; DM: diabetes mellitus.
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that provided greater and faster wound coverage in our
study population. However, there was no difference with
respect to the reamputation requirements between VAC
therapy and moist dressing treatments. We think that this
was due to the higher frequency of deeper ulcers classified
as Wagner type 3 and the longer mean wound duration in
our series. The relationship between the chronicity of the
ulceration with VAC therapy was evaluated in another
study, and they found that wound duration did not have
an overt role in the efficacy of the VAC therapy system
in patients with large wounds secondary to partial foot
amputation.19 Although we did not classify the wounds
as acute or chronic, or compare them based on this timing,
this may be the subject of another study.
Equinovarus deformity is the most common deformity
after partial foot amputation. There may often be a high-
pressure point at the anterolateral aspect of patient’s sole.
Ulceration at that region can be difficult to manage without
tendon-balancing procedure. Also in our study, anterolat-
eral aspect of the sole was the region where new ulcerations
occurred the most. However, we have no sufficient data to
conclude if the newly formed ulcerations are due to altered
foot biomechanics or progressing diabetic disorder.
There are other limitations of this study. First, it was a
retrospective study and lacked data on the progression of
granulation per week, which limited the strength of our
analysis. Second, we did not analyze the patients’ gaits,
which could alter the biomechanics of weight-bearing. It
may be possible to evaluate the relationship between the
localization of the ulcerations in partially amputated feet
with reamputation requirements.
However, the results of this study allowed us to con-
clude that NPWT as delivered through the VAC therapy
system appears to be an effective treatment for patients
with complex DFUs who had previously undergone partial
foot amputation. This could lead to a higher proportion of
healed wounds and faster healing rates compared to con-
ventional moist dressings. However, there is no superiority
of one method over the other regarding reamputation
requirements. Future studies are required for the evaluation
of the risk factors related to reamputation requirements.
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